Stock A006280 GC BIOPHARMA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GC Biopharma Corp.

Equities

A006280

KR7006280002

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 28/04/2024 BST 		5-day change 1st Jan Change
115,100 KRW +2.86% Intraday chart for GC Biopharma Corp. +5.50% -8.29%
03-20 GC Biopharma Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GC Biopharma Corp. Announces US FDA Approval for ALYGLO (Immune Globulin Intravenous, Human-Stwk) 10% Liquid for Adults with Primary Humoral Immunodeficiency (PI) CI

Evolution of the average Target Price on GC Biopharma Corp.

Price target over the last 5 years

History of analyst recommendation changes

367f8b6367ad8129.j4tCgCfjaXZHIvFoFAan4cCaEKXrRht7r3j7VBwiaMQ.xfgX32myDxMgS59QWXbFt6PMR9_YM30v5Sm3eUgSGpLM_Xb2ZdU2BxcRng~52ba289af1e4cb07740f88af3cbdb1e2

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
115,100 KRW
Average target price
144,667 KRW
Spread / Average Target
+25.69%
High Price Target
150,000 KRW
Spread / Highest target
+30.32%
Low Price Target
140,000 KRW
Spread / Lowest Target
+21.63%

Consensus detail

Consensus revision (last 18 months)

Ratings for GC Biopharma Corp.

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. A006280 Stock
  4. Consensus GC Biopharma Corp.